Market Intelligence Reports
Establish competitive intelligence’s importance to your device organization, secure resource support, and align CI with high-level strategic goals.
Deliver maximum strategic impact with a highly visible CI group structured to support strategic planners and C-level decision makers.
Chart the fiercely competitive global oncology market with detailed data for 119 brands — and launch spending benchmarks for key indications.
Track long-term forecasts and in-depth brand profiles of 45 drugs for a comprehensive look at the future of the diabetes market.
Explore analysis and forecasts for 40+ drugs in major autoimmune indications, including rheumatoid arthritis, ulcerative colitis, Crohn’s disease and more.
Harness comprehensive forecasts and strategic profiles for drugs that treat Alzheimer’s, Multiple Sclerosis and Parkinson’s.